A Study to Evaluate the Effects of a Fiber Supplement on Gut Health
2 other identifiers
interventional
50
1 country
1
Brief Summary
This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of BelliWelli Daily Fiber + Probiotics supplement on gut health over 12 weeks. One hundred participants with self-reported gut health issues will be randomized to receive either the active fiber supplement or a matched placebo product, taken twice daily. Participants will complete questionnaires and provide waist and body composition measurements at Baseline, Week 4, Week 8, and Week 12. The primary outcomes include changes in overall gut health scores, waist circumference, and body composition. Secondary outcomes include participant-perceived effects on bloating, regularity, hydration, energy, and hair, skin, and nail support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 12, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 12, 2026
CompletedFirst Submitted
Initial submission to the registry
August 5, 2026
CompletedFirst Posted
Study publicly available on registry
August 10, 2026
CompletedAugust 10, 2026
August 1, 2026
5 months
August 5, 2026
August 5, 2026
Conditions
Outcome Measures
Primary Outcomes (9)
Change in Overall Gut Health Score
Mean change in GSRS (Gastrointestinal Symptoms Rating Scale) total score from baseline as assessed via self-reported questionnaire
Baseline, Week 4, Week 8, and Week 12
Change in Bowel Movement Quality
Mean change in stool form and consistency as assessed via the Bristol Stool Scale self-reported questionnaire
Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Hydration
Mean change in self-reported hydration as assessed via self-reported questionnaire
Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Bloating
Mean change in self-reported bloating as assessed via self-reported questionnaire
Baseline, Week 4, Week 8, and Week 12
Change in Waist Circumference
Mean change in waist circumference from baseline as assessed via tape measure waist measurement
Baseline, Week 4, Week 8, and Week 12
Change in Body Weight
Mean change in body weight from baseline as assessed via Withings Smart Scale
Baseline, Week 4, Week 8, and Week 12
Change in Muscle Mass
Mean change in muscle mass from baseline as assessed via Withings Smart Scale
Baseline, Week 4, Week 8, and Week 12
Change in Fat Mass
Mean change in fat mass from baseline as assessed via Withings Smart Scale
Baseline, Week 4, Week 8, and Week 12
Change in Visceral Fat Mass
Mean change in visceral fat mass from baseline as assessed via Withings Smart Scale
Baseline, Week 4, Week 8, and Week 12
Secondary Outcomes (7)
Change in Self-Reported Regularity
Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Hydration
Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Stool Feeling
Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Energy Levels
Baseline, Week 4, Week 8, and Week 12
Change in Self-Reported Hair
Baseline, Week 4, Week 8, and Week 12
- +2 more secondary outcomes
Study Arms (2)
Active Supplement
EXPERIMENTALPlacebo Comparator
PLACEBO COMPARATORInterventions
Participants receive BelliWelli Daily Fiber + Probiotics supplement containing Collagen Peptides (Bovine) (2 g), Niacin as Niacinamide (7.5 mg), Magnesium as Magnesium Citrate (75 mg), Sodium as Sea Salt (75 mg), Potassium as Potassium Chloride (100 mg), Bacillus coagulans MTCC 5856 (10 mg / 1 billion CFU), and Acacia Fiber (4.0 g), consumed twice per day for 12 weeks.
Participants receive a taste- and appearance-matched placebo product containing Maltodextrin, Organic Cane Sugar, Natural Flavors, Citric Acid, Malic Acid, Silicon Dioxide, Stevia Leaf Extract, Beet Juice (color), and Fruit and Vegetable Juice (color), consumed twice per day for 12 weeks.
Eligibility Criteria
You may qualify if:
- Be male or female
- Be aged 18 or older
- Experiencing issues regarding all of the following over the past 4 weeks: bloating, irregular bowel movements, and self-perceived poor gut health
- Generally healthy - does not live with any uncontrolled chronic disease
- Willing to discontinue any other supplements or herbal remedies that target gut or digestive health
- Not planning on introducing any products or any new forms of prescription medication or supplements that target gut health for the study duration
- Willing to maintain current diet, sleep pattern, and activity levels for the duration
- Resides in the United States
- Not currently partaking in another research study and will not be partaking in any other research study for the next 12 weeks and at any point during this study's duration
You may not qualify if:
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries
- Anyone with any allergies or sensitivities to any of the study product ingredients
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
- Anyone who is vegan and/or does not consume animal products for any reasons
- Anyone unwilling to follow the study protocol
- Anyone with a history of substance abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Belli Welli Inc.lead
- Citruslabscollaborator
Study Sites (1)
Citruslabs
Las Vegas, Nevada, 89101, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2026
First Posted
August 10, 2026
Study Start
August 26, 2025
Primary Completion
January 12, 2026
Study Completion
January 12, 2026
Last Updated
August 10, 2026
Record last verified: 2026-08